S. V. van Buul-Offers

发表

Insulinlike growth factor—ii/mannose 6‐phosphate receptor is expressed on ccl4‐exposed rat fat‐storing cells and facilitates activation of latent transforming growth factor‐β in cocultures with sinusoidal endothelial cells

E. Wisse, V. Rogiers, T. Niki, 1995 .

A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum

B. van der Burg, P. T. van der Saag, C. E. van den Brink, 2003, Clinical endocrinology.

Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.

J. van Doorn, K. Hoekman, C. Hoogerbrugge, 2002, Clinical chemistry.

Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells.

C. Heijnen, B. Zegers, A. Schuurmans, 1992, Endocrinology.

Characterization of growth factor activity produced by fetal mouse osteoblasts.

E. J. V. van Zoelen, S. Duursma, C. Hoogerbrugge, 1990, The Journal of endocrinology.

Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line.

C. Mummery, E. J. V. van Zoelen, I. Koornneef, 1989, Endocrinology.

Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia

Changlian Zhu, K. Blomgren, F. Groenendaal, 2002, Stroke.

Human teratocarcinoma cells express functional insulin-like growth factor I receptors.

C. Mummery, E. J. V. van Zoelen, S. D. de Laat, 1989, Experimental cell research.

Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity.

J. van den Brande, S. van Buul-Offers, S. V. van Buul-Offers, 1982, Acta endocrinologica.

Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1997, Biochemical and biophysical research communications.

Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus.

E. Bonte, J. Sussenbach, S. Oei, 1995, The Journal of endocrinology.

T and B cell development in pituitary deficient insulin-like growth factor-II transgenic dwarf mice.

B. Zegers, R. Kooijman, S. van Buul-Offers, 1997, The Journal of endocrinology.

Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II

P. Roholl, L. V. D. van der Ven, S. van Buul-Offers, 1997, Histochemistry and Cell Biology.

The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy.

J. van den Brande, S. van Buul-Offers, S. V. van Buul-Offers, 1981, Acta endocrinologica.

T cell development in insulin-like growth factor-II transgenic mice.

H. Schuurman, B. Zegers, R. Kooijman, 1995, Journal of immunology.

Effects of Selective Nitric Oxide Synthase Inhibition on IGF-1, Caspases and Cytokines in a Newborn Piglet Model of Perinatal Hypoxia-Ischaemia

Changlian Zhu, K. Blomgren, F. Groenendaal, 2002, Developmental Neuroscience.

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.

Bart van der Burg, B. van der Burg, S. van Buul-Offers, 2003, The Journal of clinical endocrinology and metabolism.

Thyroxine and triiodothyronine levels in Snell mice.

S. van Buul-Offers, W. Hackeng, W. Schopman, 1983, Acta endocrinologica.

Abnormal Thymic Microenvironment in Insulin-Like Growth Factor-II Transgenic Mice

W. Savino, M. Dardenne, V. Cotta-de-Almeida, 2005, Neuroimmunomodulation.

Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation

W. Hennink, D. Crommelin, R. Verrijk, 2007, Pharmaceutical Research.

The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice.

Raoul Rooman, S. van Buul-Offers, R. Bloemen, 1999, The Journal of endocrinology.

The role of the IGF axis in IGFBP-1 and IGF-I induced renal enlargement in Snell dwarf mice.

A. Flyvbjerg, J. V. van Neck, S. Drop, 2001, The Journal of endocrinology.

Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1998, The Journal of endocrinology.

Plasma levels of insulin‐like growth factor binding protein‐4 (IGFBP‐4) under normal and pathological conditions

J. van Doorn, S. van Buul-Offers, A. J. F. H. Cornelissen, 2001, Clinical endocrinology.

Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.

J. van den Brande, C. Hoogerbrugge, J. Jansen, 1990, The Biochemical journal.

Differential patterns of insulin‐like growth factor‐I and ‐II mRNA expression in medulloblastoma

P. Wesseling, J. van Doorn, R. Reddingius, 2004, Neuropathology and applied neurobiology.

IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice.

Raoul Rooman, M. Gresnigt, S. van Buul-Offers, 2002, The Journal of endocrinology.

Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells.

S. Duursma, S. van Buul-Offers, M. Herrmann‐Erlee, 1988, The Journal of endocrinology.

A comparison of in vitro bioassays to determine cellular glucocorticoid sensitivity.

S. van Buul-Offers, A. V. Verrijn Stuart, B. I. Hendriks-Stegeman, 2004, European journal of endocrinology.